Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels.

DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Primary tabs

Sabor, Lina [UCL] Raphaël, Mélanie [UNamur] Dogné, Jean-Michel [UNamur] Mullier, François [UCL] Douxfils, Jonathan [UNamur]

Document type	Article de périodique (Journal article) – Lettre à l'éditeur
Access type	Accès restreint
Publication date	2017
Language	Anglais
Journal information	"Thrombosis Research" - Vol. 156, p. 36-38 (2017)
Peer reviewed	yes
Publisher	Pergamon Press ((United States) Elmsford, NY)
issn	0049-3848
e-issn	1879-2472
Publication status	Publié
Affiliations	UCL - SSS/IREC/MONT - Pôle Mont Godinne UCL - (MGD) Laboratoire de biologie clinique
Keywords	Apixaban ; Chromogenic anti-Xa assays ; Edoxaban ; Heparin ; Rivaroxaban
Links	http://www.ncbi.nlm.nih.gov/pubmed/28582639[Pubmed] http://hdl.handle.net/2078.1/185424[Handle] https://doi.org/10.1016/j.thromres.2017.05.024[DOI]

Bibliographic reference	Sabor, Lina ; Raphaël, Mélanie ; Dogné, Jean-Michel ; Mullier, François ; Douxfils, Jonathan. Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels.. In: Thrombosis Research, Vol. 156, p. 36-38 (2017)
Permanent URL	http://hdl.handle.net/2078.1/185424